In the BioHarmony Drug Report Database

"Preview" Icon

Vonicog alfa

Vonvendi, Veyvondi (vonicog alfa) is a protein pharmaceutical. Vonicog alfa was first approved as Vonvendi on 2018-08-31. It has been approved in Europe to treat von willebrand diseases.

 

Trade Name

 

Veyvondi
 

Common Name

 

vonicog alfa
 

ChEMBL ID

 

CHEMBL2107873
 

Indication

 

von willebrand diseases
 

Drug Class

 

Hemostatic

Image (chem structure or protein)

Vonicog alfa structure rendering